DR. ANDREW DATTILA D.O.
Prescription History 1902076821
Family Medicine in Miami, FL

Active since March 06, 2008PECOS Enrolled
9380 SUNSET DR STE B245, MIAMI, FL 33173(305) 223-0570 Get Directions

NPPES record last updated: July 1, 2021. Verified against the NPPES registry weekly; last sync: October 18, 2026.

Record update history: Jul 1, 2021, Jun 12, 2021, Feb 11, 2021 (3 updates tracked since 2021).

Medicare Part D Prescription History

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. ANDREW DATTILA D.O., an active Family Medicine specialist practicing in Miami, FL. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 480 documented patient claims. Among these therapy options, the most frequently utilized medication is Descovy, which accounts for 371 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.

4
Medications
480
Total Claims
492
30-Day Fills
Descovy
Most Prescribed · 371 claims
View details
4 medications · 2024 Medicare Part D
Medicare Part D medications prescribed by DR. ANDREW DATTILA D.O. in 2024, with prescription volumes, average cost per fill, and FL state comparisons
Medication Prescriptions (2024)Rx (2024) Avg Cost per FillCost / Fill Vs. Other FL PrescribersVs. FL Avg

About Descovy: This product is used with other HIV medications to help control HIV infection. Show more ▾

It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of two different drugs: emtricitabine and tenofovir alafenamide. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir alafenamide is called a nucleotide reverse transcriptase inhibitor. They are often called NRTIs. This product should not be used by itself to help control HIV infection. Doing so can make your treatment less effective. Use combination treatment with at least one other HIV medication. This product is also approved in the US to help prevent HIV infection in people who have a high risk for infection. Some things that increase risk include having a partner infected with HIV, having unprotected sex, having multiple sex partners, infection with a sexually transmitted disease-STD, or use/abuse of drugs or alcohol. Emtricitabine/tenofovir alafenamide is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.

In 2024, this provider wrote 371 Medicare prescriptions for Descovy, about 6.6 times the volume of the typical Florida prescriber of this medication (56.3). Medicare paid an average of $2,039.29 per fill, versus $2,189.69 statewide.

How often this provider prescribes it

This provider
371
FL average
56.3

This provider prescribes this medication more often than the average FL prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$2,039.29
FL average
$2,189.69

This provider's average cost per fill is below the FL average for this medication.

371
30-Day Fills
standardized to 30-day supplies
11,130
Days of Medication
total across all patients in 2024

About Emtricitabine-Tenofovir Disop: This product is used with other HIV medications to help control HIV infection. Show more ▾

It helps to decrease the amount of HIV in your body so your immune system can work better. This lowers your chance of getting HIV complications (such as new infections, cancer) and improves your quality of life. This product is a combination of two different drugs: emtricitabine and tenofovir. Emtricitabine is called a nucleoside reverse transcriptase inhibitor, while tenofovir is called a nucleotide reverse transcriptase inhibitor. They are often called NRTIs. This product should not be used by itself to help control HIV infection. Doing so can make your treatment less effective. Combination treatment with at least one other HIV medication should be used. This product is also used to help prevent HIV infection in people who have a high risk for infection. Some things that increase risk include having a partner infected with HIV, having unprotected sex, having multiple sex partners, infection with a sexually transmitted disease-STD, or use/abuse of drugs or alcohol. Emtricitabine/tenofovir is not a cure for HIV infection. To decrease your risk of spreading HIV disease to others, continue to take all HIV medications exactly as prescribed by your doctor. Use an effective barrier method (latex or polyurethane condoms/dental dams) during sexual activity as directed by your doctor. Do not share personal items (such as needles/syringes, toothbrushes, and razors) that may have contacted blood or other body fluids. Consult your doctor or pharmacist for more details.

In 2024, this provider wrote 83 Medicare prescriptions for Emtricitabine-Tenofovir Disop, about 3.4 times the volume of the typical Florida prescriber of this medication (24.6). Medicare paid an average of $168.49 per fill, versus $198.00 statewide.

How often this provider prescribes it

This provider
83
FL average
24.6

This provider prescribes this medication more often than the average FL prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$168.49
FL average
$198.00

This provider's average cost per fill is below the FL average for this medication.

95
30-Day Fills
standardized to 30-day supplies
2,850
Days of Medication
total across all patients in 2024

About Ibuprofen: Ibuprofen is used to relieve pain from various conditions such as headache, dental pain, menstrual cramps, muscle aches, or arthritis. Show more ▾

It is also used to reduce fever and to relieve minor aches and pain due to the common cold or flu. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. This effect helps to decrease swelling, pain, or fever. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. See also Warning section. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar names may contain different ingredients meant for different purposes. Taking the wrong product could harm you. A non-steroidal anti-inflammatory agent with analgesic, antipyretic, and anti-inflammatory properties

In 2024, this provider wrote 15 Medicare prescriptions for Ibuprofen, about a third of the volume of the typical Florida prescriber of this medication (41.3). Medicare paid an average of $3.85 per fill, versus $6.63 statewide.

How often this provider prescribes it

This provider
15
FL average
41.3

This provider prescribes this medication less often than the average FL prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$3.85
FL average
$6.63

This provider's average cost per fill is below the FL average for this medication.

15
30-Day Fills
standardized to 30-day supplies
450
Days of Medication
total across all patients in 2024

About Oxycodone Hcl: This medication is used to help relieve moderate to severe pain. Show more ▾

Oxycodone belongs to a class of drugs known as opioid analgesics. It works in the brain to change how your body feels and responds to pain. A semisynthetic derivative of CODEINE.

In 2024, this provider wrote 11 Medicare prescriptions for Oxycodone Hcl, about 12% of the volume of the typical Florida prescriber of this medication (90.4). Medicare paid an average of $32.26 per fill, versus $19.04 statewide.

How often this provider prescribes it

This provider
11
FL average
90.4

This provider prescribes this medication less often than the average FL prescriber. Utilization reflects practice size as well as clinical preference.

What Medicare paid per fill

This provider
$32.26
FL average
$19.04

Gross Part D cost per fill; not the patient's out-of-pocket price.

11
30-Day Fills
standardized to 30-day supplies
318
Days of Medication
total across all patients in 2024
No medications match the current filters.
▲ More than typical≈ Typical▼ Less than typical= prescription volume vs the average FL prescriber of the same medication; volume reflects practice size as well as clinical preference.Green cost= below the FL average cost per fill.

About this data. The prescription history for DR. ANDREW DATTILA D.O. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Family Medicine prescribing approach at this Miami, FL practice.

Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among FL prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.

About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.